Home / NanoBRET


287 NanoBRETTM assay for monitoring of ligand binding to GPCRs in live cells using the CLARIOstar® and the PHERAstar FS
Leigh A. Stoddart(1), Elizabeth K. M. Johnstone(2,3), Amanda J. Wheal(1), Joëlle Goulding(1), Matthew B. Robers(4), Thomas Machleidt(4), Giovanni Abbenante(5), Keith V. Wood(4), Stephen J. Hill(1-3), and Kevin D. G. Pfleger(2,3)1 Cell Signalling Research Group, School of Life Sciences, The University of Nottingham Medical School, Nottingham, United Kingdom.2 Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.3 Centre for Medical Research, The University of Western Australia, Crawley, Western Australia, Australia.4 Promega Corporation, Madison, Wisconsin, United States.5 BMG LABTECH Pty Ltd, Mornington, Victoria, Australia.




Reader Methods

Top Tags